molecular beacons

 

    Patent and Patent Applications

  1. Hybridization Probes for Nucleic Acid Detection, Universal Stems, Methods and Kits
    (Filed in Australia, Canada, Europe and Japan) - Now Expired

  2. Detectably Labeled Dual Conformation Oligonucleotide Probes, Assays and Kits
    (Filed in Australia, Canada, Europe, Japan and the United States) - Now Expired

  3. Nucleic Acid Detection Probes Having Non-FRET Fluorescence Quenching
    and Kits and Assays Including Such Probes

    (Filed in Australia, Canada, Europe, Japan and the United States) - Now Expired

  4. Non-Competitive Co-Amplification Methods
    (Filed in Australia, Canada, Japan and the United States) - Now Expired

  5. Wavelength-Shifting Probes and Primers and Their Use in Assays and Kits
    (Filed in Australia, Canada, Europe, Japan and the United States) - Now Expired

  6. Assays for Short Sequence Variants
    (Filed in Australia, Canada, Europe, Japan and the United States) - Still Valid

    US patent US766255
    European patent EP1230387

  7. Homogenous Multiplex Screening Assays and Kits
    (Filed in Australia, Canada, China, Europe, Japan and the United States) - Still Valid

    US patent US07385043


  To top of page



www www.molecular-beacons.org




Recent Publications from our group


Banada PP, Green R, Streck D, Kurathi R, Reiss R, Banik S, Montalvan I, Jones R, Marras SAE, Chakravorty S, and Alland D (2023) An expanded RT-PCR melting temperature coding assay to rapidly identify all known SARS-CoV-2 variants and sub-variants of concern. Scientific Reports 13. 21927. PMID: 38081834: PubMed Link

Ebraham L, Xu C, Wang A, Hernandez C, Siclari N, Rajah D, Walter L, Marras SAE, Tyagi S, Fine DH, Daep CA, and Chang TL (2023) Oral Epithelial cells expressing low or undetectable levels of human angiotensin-converting enzyme 2 are susceptible to SARS-CoV-2 virus infection in vitro. Pathogens 12. PMID: 37375533: PubMed Link